PharmTech News

Articles

FDA's efforts to improve access to treatments for rare diseases.

Global Healthcare on the Ground: FDA Tackles Rare Diseases

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

Bristol-Myers Squibb opens a new pediatric HIV/AIDS clinic in Tanzania.

Bristol-Myers Squibb Moves Forward with HIV/AIDS Project in Africa

This article is Part I of a three-part series on biopharmaceutical issues in public health, government, and developing-world markets. Part 1 focuses on drug-development. Part II, which examines manufacturing, appeared in the April 2011 of Sourcing and Management. Part III, which analyzes distribution and administration,appeared in the May 2011 issue.

Drug Development for Government, Nonprofit, and Developing-World Markets

The Novartis Foundation for Sustainable Development held a symposium in December 2010 to continue dialogue on how the private and public sector can work together in achieving the UN Millennium Development Goals.

Novartis Participates in Achieving the UN Millennium Development Goals

Angie Drakulich was editorial director of Pharmaceutical Technology.

USP helps to improve drug quality in 32 countries.

Global Healthcare on the Ground: USP

One year following the earthquake in Haiti, the pharmaceutical industry and private sector participate in efforts for long-term relief.

Pharmaceutical and Business Leaders Focus on Haiti

The Global Health Progress collaboration works to improve healthcare delivery in the developing world.

Global Healthcare on the Ground: Global Health Progress Initiative

Tiered pricing is used throughout industry to help increase affordability and access to drugs in the developing world.

Global Healthcare on the Ground: Differential Pricing

The prevention and treatment of noncommunicable diseases is becoming an increasingly important consideration in global health initiatives.

Targeting Noncommunicable Diseases in Global Health

Merck and AstraZeneca Tackle Cervical Cancer and Tuberculosis.

Bio/Pharma News